Fetal Diagnosis and Therapy

 

Hydrops Fetalis, Thickened Placenta and Other Sonographic Findings in a Low-Level Trisomy 21 Mosaicism: A Case Report

Sifakis S.a · Koukoura O.a · Mantas N.a · Velissariou V.b · Koumantakis E.a

Author affiliations

aDepartment of Obstetrics and Gynecology, University Hospital of Heraklion, Heraklion, and bDepartment of Genetics and Molecular Biology, Mitera Hospital, Athens, Greece

Related Articles for ""

Fetal Diagn Ther 2008;24:310–312

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Received: December 27, 2006
Accepted: July 16, 2007
Published online: October 03, 2008
Issue release date: October 2008

Number of Print Pages: 3
Number of Figures: 2
Number of Tables: 0

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT

Abstract

We report a case of trisomy 21 mosaicism detected upon amniocentesis in a 36-year-old woman. Ultrasound examination at 23weeks’ gestation showed a fetus with hydrops, pulmonary hypoplasia, oligohydramnios, thickened placenta, and intrauterine growth retardation. Cytogenetic analysis revealed low-percentage (6%) mosaicism for trisomy 21. Hydrops fetalis and thickened placenta are uncommon findings in fetuses affected by trisomy 21 mosaicism. A short review of the literature is given regarding the sonographic findings associated with trisomy 21 mosaicism, and the genetic counseling in such cases.

© 2008 S. Karger AG, Basel




Related Articles:


References

  1. Hsu LY, Yu MT, Richkind KE, Van Dyke DL, Crandall BF, Saxe DF, et al: Incidence and significance of chromosome mosaicism involving an autosomal structural abnormality diagnosed prenatally through amniocentesis: a collaborative study. Prenat Diagn 1996;16:1–28.
  2. Niikawa N, Kajii T: The origin of mosaic Down syndrome: four cases with chromosome markers. Am J Hum Genet 1984;36:123–130.
  3. Morris JK, Wald NJ, Watt HC: Fetal loss in Down syndrome pregnancies. Prenat Diagn 1999;19:142–145.
  4. Hsu LYF, Kaffe S, Jenkins EC, Alonso L, Benn PA, David K, et al: Proposed guidelines for diagnosis of chromosome mosaicism in amniocytes based on data derived from chromosome mosaicism and pseudomosaicism studies. Prenat Diagn 1992;12:555–573.
  5. Ilagan NB, Liang KC, Delaney Black V, Perrin E: Hydrops fetalis polyhydramnios, pulmonary hypoplasia and Down syndrome. Am J Perinatol 1992;9:9–10.
  6. Puddy V, Lam BC, Tang M, Wong KY, Lam YH, Wong K, et al: Variable levels of mosaicism for trisomy 21 in a non-immune hydropic infant with chylothorax. Prenat Diagn 1999;19:764–766.
  7. Astner A, Schwinger E, Caliebe A, Jonat W, Gembruck U: Sonographically detected fetal and placental abnormalities associated with trisomy 16 confined to the placenta. A case report and review of the literature. Prenat Diagn 1998;18:1308–1315.
  8. Harper MA, Ruiz C, Pettenati MJ, Rao PN: Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening. Obstet Gynecol 1994;83:844–846.
  9. Qureshi F, Jacques SM, Johnson MP, Hume RF, Kramer RL, Yaron Y, et al: Trisomy 21 placentas: histopathological and immunohistochemical findings using proliferating cell nuclear antigen. Fetal Diagn Ther 1997;12:210–215.
  10. Massin N, Frendo JL, Guibourdenche J, Luton D, Giovanandi Y, Muller F, et al: Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down’s syndrome. Placenta 2001;22(suppl A):S93–S97.
  11. Wegrzyn P, Faro C, Falcon O, Peralta CF, Nicolaides KH: Placental volume measured by three-dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol 2005;26:28–32.
  12. Jauniaux E, Gavrill P, Khun P, Kurdi W, Hyett J, Nicolaides KH: Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness. Hum Reprod 1996;11:435–439.
  13. Wallerstein R, Yu MT, Neu RL, Benn P, Lee Bowen C, Crandall B, et al: Common trisomy mosaicism diagnosed in amniocytes involving chromosomes 13, 18, 20 and 21: karyotype-phenotype correlations. Prenat Diagn 2000;20:103–122.
  14. Hsu LY, Yu MT, Neu RL, Van Dyke DL, Benn PA, Bradshaw CL, et al: Rare trisomy mosaicism diagnosed in amniocytes, involving an autosome other than chromosomes 13, 18, 20, and 21: karyotype/phenotype correlations. Prenat Diagn 1997;17:201–242.
  15. Brisset S, Aboura A, Audibert F, Costa JM, L’Hermine AC, Gautier V, et al: Discordant prenatal diagnosis of trisomy 21 due to mosaic structural rearrangements of chromosome 21. Prenat Diagn 2003;23:461–469.

Article / Publication Details

First-Page Preview
Abstract of Paper

Received: December 27, 2006
Accepted: July 16, 2007
Published online: October 03, 2008
Issue release date: October 2008

Number of Print Pages: 3
Number of Figures: 2
Number of Tables: 0

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP